About IJPDT
1. | DEVELOPMENT AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEMS FOR PRAVASTATIN | |||||
Bhargavi D*, Jayachandra Reddy P, Umasankar K | ||||||
|
||||||
Pravastatin is a cholesterol-lowering agent that belongs to a class of medications known as statins. The present work is to |
||||||
2. | DESIGN OF LOTIONS INCORPORATING CROCUS FOR SUNSCREEN | |||||
K. Mahender*, C.R,Akila, K. Mothilal, K. Chaitanya Kumar, D. Ravi | ||||||
|
||||||
Ultra violet ray absorption is reduced by applying sunscreen reaches the skin and also reduces sun induced diseases such |
||||||
3. | COMPARISON OF DEXMEDETOMIDINE AND CLONIDINE (ALPHA2 AGONIST DRUGS) AS AN ADJUVANT TO LOCAL ANAESTHESIA IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK: A PROSPECTIVE DOUBLE-BLIND STUDY | |||||
Sivaraj N1 and Jaikumar S | ||||||
|
||||||
Addition of adjuvants to local anaesthetic in supraclavicular brachial plexus Block helps in improving duration of block and analgesia. We compare clonidine and Dexmedetomidine in supraclavicular brachial plexus block. Method: A total of 80 patients aged from 20 to 55 years belonging to ASA I-II scheduled for Upper limb surgery were included and divided into three groups- Group I received 0.5%, normal saline, Group II received 0.5% clonidine and Group III dexmedetomidine. The patients were compared for onset as well as duration of sensory and motor blockade, duration of analgesia and haemodynamic Side effects. Results: The mean duration of sensory and motor block as well as analgesia was found to be More (statistically highly significant p<0.001) in group III (dexmedetomidine group) having A much longer duration of sensory and motor block as well as analgesia compared to group I and group II (clonidine group). Conclusion: Therefore, in present study it was found that addition of clonidine and Dexmedetomidine are effective in supraclavicular brachial plexus block. However, dexmedetomidine is a better alternative to clonidine as adjuvant to obtain early onset and prolong the duration of sensory and motor block and Postoperative analgesia
|
||||||
4. | FORMULATION AND CHARACTERIZATION OF AZTREONAM IV INFUSION | |||||
Balasubramanian V, Senthil Kumar K L, Vijaya K | ||||||
|
||||||
Intravenous fluid administration should be considered as any other pharmacological prescription. There are three main
indications: resuscitation, replacement, and maintenance. Moreover, the impact of fluid administration as drug diluent or to
preserve catheter patency should also be considered. As for antibiotics, intravenous fluid administration should follow the four
Ds: drug, dosing, duration, de-escalation. Among crystalloids, balanced solutions limit acid–base alterations and chloride load and
should be preferred, as this likely prevents renal dysfunction. Among colloids, albumin, the only available natural colloid, may
have beneficial effects. The last decade has seen growing interest in the potential harms related to fluid overloading. In the fluid
management that maintains adequate organ perfusion while limiting fluid administration should represent the standard of care.
Protocols including a restrictive continuous fluid administration alongside bolus administration to achieve hemodynamic targets
have been administered
|
||||||